Loading...

Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus

BACKGROUND: Gastrointestinal (GI) symptoms are common in patients with type 2 diabetes mellitus (T2DM). Rebamipide is an effective gastric cytoprotective agent, but there are few data on its usefulness in T2DM. The aim of this study is to evaluate the improvement of GI symptoms after rebamipide trea...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diabetes Metab J
Main Authors: Park, Sejeong, Park, So Young, Kim, Yu Jin, Hong, Soo Min, Chon, Suk, Oh, Seungjoon, Woo, Jeong-taek, Kim, Sung-Woon, Kim, Young Seol, Rhee, Sang Youl
Format: Artigo
Sprog:Inglês
Udgivet: Korean Diabetes Association 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4929228/
https://ncbi.nlm.nih.gov/pubmed/27098506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2016.40.3.240
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!